Camurus AB (publ)
Status: Publicly traded
Direct answer
Camurus AB (publ) is publicly traded on LSE under the ticker 0RD1.L.
Camurus AB (publ), a pharmaceutical firm established in Lund, Sweden, in 1991, specializes in creating and bringing to market therapeutic solutions for debilitating and long-term health conditions. The company operates globally, with a presence in Europe, Australia, the United States, Japan, and other international markets. Its current commercial offerings include Buvidal and Brixadi, both injectable buprenorphine...
Can you invest in Camurus AB (publ)?
Yes. Camurus AB (publ) trades publicly on LSE as 0RD1.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Camurus AB (publ)
Detailed equity research is provided by MarketSnap.